Ventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Ventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Antiarrhythmics Versus Implantable Defibrillators (AVID) [Phase 3]
Phase 3 AVID trial comparing amiodarone (antiarrhythmic drug therapy) to implantable defibrillators in patients with ventricular arrhythmias…
-
CLINICAL_TRIALS withdrawal · 2016-04-06Clinical Trial Update: Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia [Phase 4]
A Phase 4 clinical trial comparing intravenous amiodarone versus intravenous procainamide for haemodynamically well-tolerated ventricular ta…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Fatty Acid Antiarrhythmia Trial (FAAT) [Phase 3]
Phase 3 clinical trial FAAT, sponsored by the National Heart, Lung, and Blood Institute, has completed evaluating a fatty acid–based antiarr…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Antiarrhythmic Effects of N-3 Fatty Acids [Phase 2]
Phase 2 trial evaluating whether N-3 fatty acids (omega-3 fatty acids) have antiarrhythmic effects in patients with arrhythmias, including v…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) [Phase 3]
This is a Phase 3 clinical trial comparing electrophysiologic study versus electrocardiographic monitoring for arrhythmia outcomes. The tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Shockless Implant Evaluation [NA]
A completed clinical trial evaluating a Shockless Implant for ventricular fibrillation and ventricular tachycardia has posted results in 201…
-
CLINICAL_TRIALS withdrawal · 2015-12-09Clinical Trial Update: The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
This record notes that the clinical trial for the PD2i Cardiac Analyzer to predict ventricular tachyarrhythmic events has been withdrawn.
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients
ClinicalTrials.gov entry reports on the completed study evaluating the impact of ventricular pacing in unselected ICD/CRT-D patients.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention [Phase 4]
Phase 4 trial comparing anti-arrhythmic drug therapy versus catheter ablation as the first-line strategy to prevent implantable cardioverter…
-
FDA approval · 2015-10-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
FDA label_change · 2015-09-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (ALTATHERA Pharmaceuticals, LLC)
The FDA approved a supplemental application for Sotalol Hydrochloride submitted by ALTATHERA Pharmaceuticals, LLC, to modify the product lab…
-
CLINICAL_TRIALS research · 2015-09-25Clinical Trial Update: Botulinum Toxin Injection to Prevent Ventricular Arrhythmias [Phase 1]
Phase 1 study evaluating botulinum toxin injections to prevent ventricular arrhythmias in patients with symptomatic ventricular asystole or …
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Botulinum Toxin Injection to Prevent VT Storm [Phase 1]
Phase 1 clinical trial is evaluating botulinum toxin injections to prevent ventricular tachycardia storm; current status is unknown.
-
CLINICAL_TRIALS research · 2015-09-07Clinical Trial Update: SmartTouch Catheter in Ablation of Ventricular Tachycardia
The document provides an update on a clinical trial evaluating the SmartTouch Catheter for ablation of ventricular tachycardia, with the tri…
-
CLINICAL_TRIALS research · 2015-09-04Clinical Trial Update: A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data
This update reports on a feasibility study investigating whether data derived from an implanted cardioverter-defibrillator can predict an IC…
-
FDA approval · 2015-08-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sotalol hydrochloride from Aurobindo Pharma Limited. The approval confirms the generic product's…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia [Phase 4]
Phase 4 update on the Stereotaxis system for ablation of persistent ventricular tachycardia, with results posted in 2015.
-
FDA approval · 2015-08-13FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) from Upsher-Smith Laboratories.
-
FDA approval · 2015-08-13FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propafenone hydrochloride (Propafenone HCl) from Actavis Pharma, Inc.
-
FDA approval · 2015-07-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride by Advagen Pharma Limited. This action confirms regulatory clearance fo…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study
The Stereotaxis idiopathic ventricular tachycardia study has been terminated, ending any further enrollment or follow-up.
-
FDA approval · 2015-05-19FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Amiodarone Hydrochloride (generic) from Chartwell RX, LLC, confirming the generic product's stat…
-
FDA approval · 2015-04-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for sotalol hydrochloride by Oxford Pharmaceuticals, LLC. Sotalol is used to treat certain heart…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intravenous omega-3 fatty acids in patients with an implantable cardioverter-defibrillator/pacemaker h…
-
FDA approval · 2015-03-13FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
The FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company.